Wondering if anyone knows why Aminoglycosides are not on the NIOSH list since they are known to cause ototoxicity to the unborn fetuses?

what does your hospital do when administering amikacin/tobramycin as a nebulization?
Do the parents/guardians leave the room? what happens to the next patient/family in the next bed?

We are an Epic health system and recently implemented a best practice advisory prompting an oncology consult when a provider tried to continue a home oral chemotherapy during admission med reconciliation. We still have instances where the oral agent was continued without the consult or was continued upon discharge with discharge med rec. Has anyone blocked ordering to just oncology or have a different solution that has worked at your location?

We are going to the gemba to understand our workflows of med admin through observation. If there is a system that is willing to share a med admin observation tool they have used, please attach. Thank you in advance!

Terry Bosen, PharmD
Vanderbilt University Medical Center
Nashville, TN

Good morning,

We use Cerner and are trying to restrict MAR documentation of respiratory therapist to just inhaled routes for medications that can also be given using other routes (i.e., acetylcysteine, tobramycin, etc). This is a concern because of the risk of incorrectly documenting on IV orders.

Has anyone been successful in restricting MAR documentation for respiratory therapists to just inhaled and nebulized routes?

Thank you,
Julieth Formosa

It appears that some states are opening up Class J licenses for Pharmacies to participate in shared services (covering clinical, operational, and/or other medication management functions for another pharmacy campus).

One requirement is to have a QA process. Which other health-systems are pursuing this level of license? How do you have your QA process set-up? Which metrics have you considered?

Thank you in advance,
Joel

#

Hi everyone,

We are interested to see if any institutions have experience with outpatient clinics that might see a mixed age group (adults and pediatrics)?

And if so, what are some best practices used at your institution to store medications?

Thank you!
Susan

Greetings,
Our institution has anecdotally noticed an uptick in iron sucrose adverse drug reactions. Is this occurring anywhere else? Our infusion center uses the branded Venofer product.

Sloane Hoefer, PharmD, BCPS
Nebraska Medicine

Good Afternoon,
When a CVC line is locked with a medication such as heparin or an antibiotic, does anybody use a visual flag (e.g., label) or do you rely on the MAR documentation? If you are using visual identification on the line, could you please share a visual of the label. What company makes the labels and please provide ordering information utilized.

Thank you!

Carley

Hello all,

I wanted to reach out to see if any of you have enacted the recommendation from ISMP to disable your nonspecified prn dosing frequencies (e.g., BID prn or TID prn) in Feb 2022?

1. If so, did you completely delete those and only allow for specified prn frequencies like q6h prn?
2. What did you do about home medication reconciliation? What happens if on patient's pill bottles that way (especially in ambulatory settings)?
3. How did you pursue approval through your respective institutions? Provider feedback?

Is anyone using Lumason contrast? Have you had any anaphylaxis reactions? We switched from Difinity last fall and recently had 2 anaphylaxis reactions within the past month. The radiologists now want to switch back. The rep says there have been no reports in her region so wondering what others are seeing with this product. Thank you!